Mar. 18 at 11:37 AM
$IRWD Disclosure: I’m not in this one anymore, other than a few options. However, just to add a little to Denner’s recent sale. He did own shares of ARRY Biopharma and he sold his entire position in the 6’s as he was not aligned with management and the board. About 2 years later, the company was acquired for
$48 a share by PFE. A much higher premium than Denner’s history.
